Commercial Division Denies Pfizer’s Motion To Dismiss, Holds Allergan’s Claims for Defense Costs Are Ripe
Equitable Tolling: “Estopping” the Clock from Running on Your Claims
Commercial Division Judge Reaffirms “Most Critical” Element for Injunctive Relief: Irreparable Harm
Affirmatively Plead Your Defenses, or Risk “Waiving” Them Goodbye
Three New Rule Amendments Proposed by the Commercial Division Advisory Council
New York, Not Swiss Law Applies to Lawsuit Over “Stolen” $40M Princie Diamond
Summary Judgment 102: Make Sure Your “Money Instrument” Is In Tune With CPLR 3213
Summary Judgment 101: Movants, Make Sure Your Evidence Is In “Admissible Form”
